Format

Send to

Choose Destination
Methods. 2020 Jan 6. pii: S1046-2023(19)30266-X. doi: 10.1016/j.ymeth.2020.01.001. [Epub ahead of print]

Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.

Author information

1
Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Australia.
2
Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Australia. Electronic address: andrew.hill@latrobe.edu.au.

Abstract

Extracellular vesicles (EVs) are membrane bound vesicles released into the extracellular environment by eukaryotic and prokaryotic cells. EVs are enriched in active biomolecules and they can horizontally transfer the cargo to distant recipient cells. In recent years EVs have demonstrated promising clinical applications due to their theragnostic potential. Although EVs have promising therapeutic potential, there are several challenges associated with using EVs before transition from the laboratory to clinical use. Some of these challenges include issues around low yield, isolation and purification methodologies, and poor engineering (loading) of EVs with therapeutic cargo. Also, to achieve higher therapeutic efficiency, EVs architecture and cargo may need to be manipulated prior to clinical application. Some of these issues have been addressed by developing biomimetic EVs. EV mimetic-nanovesicles (M-NVs) are a type of artificial EVs which can be generated from all cell type with comparable characteristics as EVs for an alternative therapeutic modality. In this review, we will discuss current techniques for modifying EVs and methodology used for generation and customizing of EVs mimetic-nanovesicles.

KEYWORDS:

Extracellular vesicles; cargo modification; engineering; exosome mimetic-nanovesicles; therapeutic loading

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center